MANGALAMBSEMANGALAM DRUG & CHEM LTDHighNeutral
Announced Wed, 12 Aug · 17:16 IST

Q1FY27 Results: Loss Narrows to Rs 7.55 Cr; New Auditors Appointed

Pat NegativeAuditor Mid Year ChangeResults View source PDFExplain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹27.11
prior close
₹27.13
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2-1.2-1.0-0.8+3.3+2.4+3.2-0.4-0.9+12.3+13.5+23.0
Up moveDown movePending
AI summary

Board approved Q1FY27 (June 2026) unaudited results. Revenue at Rs 57.12 Cr vs Rs 57.21 Cr YoY, broadly flat. Standalone net loss narrowed to Rs 7.55 Cr (Rs 4.77 per share) vs Rs 13.73 Cr loss YoY. Consolidated net loss at Rs 7.64 Cr vs Rs 13.80 Cr YoY. New statutory auditor S.N. Nanda and Co appointed for 5 years. L.N. Joshi and Co named secretarial auditor. Auditor issued a clean limited review.

Likely market impact

Loss narrowed sharply YoY but stock still in red; flat revenue is a concern; new auditor appointed for 5-year term.